LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer

author
created [InstanceEdit:9652923] Rothfels, Karen, 2019-07-09
dbId 9652925
displayName LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer
journal Oncotarget
pages 9251-9266
pubMedIdentifier 27999210
schemaClass LiteratureReference
title LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer
url http://www.ncbi.nlm.nih.gov/pubmed/27999210
volume 8
year 2017
Cite Us!